Category

News

Exocrine Pancreatic InsufficiencyNewsPatient ResourcesTopicsWebinarsWebinars: Exocrine Pancreatic Insufficiency (EPI) & Pancreatic Enzymes
March 8, 2019

Pancreatic Enzyme Replacement Therapy – New Information for Pancreatitis Patients on Treating EPI

Busting the Myths about Pancreatic Enzymes for Pancreatitis and EPI Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presents Busting the Myths about Pancreatic Enzymes for Pancreatitis. In this webinar, the fifth in Mission: Cure’s Patient and Family Webinar Series, Dr. Freedman explains: What causes exocrine pancreatic insufficiency (EPI)? How is EPI diagnosed and treated? When…
News
March 1, 2019

Potential Chronic Pancreatitis Treatments Identified

On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month "datathon" aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures for pancreatitis. New Pancreatitis Treatment…
GeneticsNewsPatient ResourcesRepurposing DrugsWebinars
December 9, 2018

Curing Pancreatitis: It’s Time for a New Approach!

https://youtu.be/BOmLjiVIX6c On December 8th, Mission: Cure hosted an informational webinar for chronic and recurrent acute pancreatitis patients, their families and clinicians on their new approach to curing pancreatitis. It featured co-directors Megan Golden and Linda Martin, who gave presentations on the gap Mission: Cure is working to address, their innovative financing model, and how patients and families can get involved…
News
July 11, 2018

N=1 Drug Discovery Pact: Mission: Cure’s New Partnership with Perlara

Mission: Cure believes that new innovations in medical research are key to achieving our goal of curing chronic pancreatitis. For this reason, we strive to leverage and support advances in genomics and precision medicine and aim to collaborate with forward-thinking and mission-driven organizations. Today, we are excited to announce our partnership with Perlara, a rare disease drug discovery platform company working with…
News
May 9, 2018

Mission: Cure News and Updates May 2018

Mission: Cure aims to demonstrate a new model for curing disease, leveraging outcome-based financing and impact investing. Our first mission is to find a cure for CHRONIC PANCREATITIS, a painful and disabling disease that affects 150,000 people, including 10,000 children. Our goal is to accelerate the development of promising new treatments and find a cure. But we can't do it…
News
November 2, 2017

New Venture Launched to Harness Innovative Financing and Impact Investing to Cure Disease; “Mission: Cure” Pioneers New Approach by Attacking Pancreatic Disease

FOR IMMEDIATE RELEASE “Mission: Cure” Launched to Harness Innovative Financing and Impact Investing to Cure Disease; Pioneers New Approach by Attacking Pancreatic Disease New York, New York, Tuesday, November 7, 2017—The new nonprofit Mission: Cure will convene the world’s leading pancreatic experts at the American Pancreatic Association meeting in San Diego on November 10th to devise a 10-year plan to…